In July 2023, WIXBIO welcomed a customer delegation from Nigeria. The two sides had an in-depth discussion on the customized cooperation of poultry vaccines and veterinary drugs. The visit not only strengthened WIXBIO’s ties with the Nigerian market but also laid a solid foundation for future cooperation.
Highlights of the negotiation
Visit to R&D facilities: The Nigerian customer delegation visited WIXBIO’s R&D center and learned in detail about the company’s advanced technology and strict vaccine R&D, production, and quality control standards.
Product demonstration: WIXBIO showcased its latest avian vaccine and veterinary products, including highly effective solutions for various common diseases. These products are developed with advanced biotechnology and can significantly improve animals’ immunity.
Customized services: WIXBIO’s technical team introduced the company’s customized services, which can provide tailor-made vaccine and veterinary solutions according to the needs of the Nigerian market.
Intention to cooperate: The two sides reached a preliminary consensus on future cooperation in the field of poultry vaccines and veterinary drugs and discussed the specific mode and timetable of collaboration.
Customer Feedback
The Nigerian customer delegation highly praised WIXBIO’s innovation ability and product quality. They said that WIXBIO’s products and services fully meet their needs and look forward to establishing long-term and stable cooperation with WIXBIO to jointly promote the development of the avian medical industry in Nigeria.
Future Prospects
WIXBIO will continue to dedicate itself to technological innovation, introduce more efficient and environmentally friendly vaccines and veterinary products, and strengthen cooperation with global partners. Through this cooperation, we look forward to providing better services to Nigeria and other international markets and jointly promoting the healthy and sustainable development of the worldwide livestock industry.
这是一段文字内容。这是一段文字内容。这是一段文字内容。这是一段文字内容。这是一段文字内容。
- 1
- 2
- 3
- 4
- 5
- 6
- 7
这是一段文字内容。这是一段文字内容。这是一段文字内容。这是一段文字内容。这是一段文字内容。
- 1
- 2
- 3
- 4
- 5
- 6
- 7
